多重特異的抗原結合タンパク質
ＣＨ１ドメインとＣＫドメインとの間の二量体化から形成され、且つ２つの標的抗原に結合する多量体多重特異的タンパク質が提供される。このタンパク質は、産生と、疾患、特に癌又は感染疾患の処置とにおいて利点を有する。.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Europäisches Patentamt - (2017) vom: 02. Nov. Zur Gesamtaufnahme - year:2017 |
|---|
| Sprache: |
Japanisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2017-11-02, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
JP2017532287 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002820595 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002820595 | ||
| 003 | DE-627 | ||
| 005 | 20240426160120.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2017 xx |||||o 00| ||jpn c | ||
| 035 | |a (DE-627)EPA002820595 | ||
| 035 | |a (EPA)JP2017532287 | ||
| 035 | |a (EPA)53476895 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 245 | 1 | 0 | |a 多重特異的抗原結合タンパク質 |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2017-11-02, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 | ||
| 520 | |a ＣＨ１ドメインとＣＫドメインとの間の二量体化から形成され、且つ２つの標的抗原に結合する多量体多重特異的タンパク質が提供される。このタンパク質は、産生と、疾患、特に癌又は感染疾患の処置とにおいて利点を有する。 | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2017) vom: 02. Nov. |
| 773 | 1 | 8 | |g year:2017 |g day:02 |g month:11 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/53476895/publication/JP2017532287A1?q=JP2017532287 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2017 |b 02 |c 11 | ||